Metabolically Distinct Phenotypes of Polycystic Ovary Syndrome Identified from Seven Routinely Measured Variables: A Cross-Sectional Study in Real-World Clinical Practice

Polycystic ovary syndrome (PCOS) is clinically heterogeneous, and analysis of incomplete clinical data may reveal clinically meaningful patterns. We investigated whether routinely measured variables could identify interpretable PCOS phenotypes in 1735 women diagnosed according to the Rotterdam criteria. Unsupervised clustering used body mass index (BMI), fasting glucose, fasting insulin, total testosterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and sex hormone-binding globulin (SHBG) across multiply imputed datasets. Phenotypes were characterized using additional reproductive, androgenic, and metabolic traits. Metabolic analyses were adjusted for age and BMI, with sensitivity analyses for missing postload outcomes. Two phenotypes were identified, Metabolic-PCOS in 657 women (37.9%) and Reproductive-PCOS in 1078 (62.1%). Reproductive-PCOS showed a gonadotropin-predominant profile, whereas Metabolic-PCOS showed a less favorable metabolic profile. Separation between these profiles was modest, supporting their interpretation as predominant clinical patterns rather than sharply distinct categories. Metabolic-PCOS also had higher 2-h glucose, 120-min insulin, triglycerides, low-density lipoprotein cholesterol (LDL-C), and uric acid, which were not used for phenotype derivation. After adjustment, 2-h glucose was 16.4% higher, 120-min insulin was 111.6% higher, and the odds of elevated 2-h glucose (≥7.8 mmol/L) were greater (odds ratio [OR] 3.98, 95% confidence interval [CI] 2.62 to 6.04). Findings were consistent across sensitivity analyses. This parsimonious biomedical data mining approach identified clinically interpretable PCOS phenotypes that warrant external and prospective validation for metabolic risk stratification.

Authors

Institutions

Publication Details

Journal
Bioengineering
Published
2026-11-13
DOI
https://doi.org/10.3390/bioengineering13111351
Primary Topic
Ovarian function and disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Metabolically Distinct Phenotypes of Polycystic Ovary Syndrome Identified from Seven Routinely Measured Variables: A Cross-Sectional Study in Real-World Clinical Practice

Zhouzhou Bao, 狄文, Zhuowei Gu, Hua Gao et al.
1 links
Bioengineering
Ovarian function and disorders
article

Metabolically Distinct Phenotypes of Polycystic Ovary Syndrome Identified from Seven Routinely Measured Variables: A Cross-Sectional Study in Real-World Clinical Practice

Zhouzhou Bao, 狄文, Zhuowei Gu, Hua Gao, Xuejiao Bian
article en

Abstract

Polycystic ovary syndrome (PCOS) is clinically heterogeneous, and analysis of incomplete clinical data may reveal clinically meaningful patterns. We investigated whether routinely measured variables could identify interpretable PCOS phenotypes in 1735 women diagnosed according to the Rotterdam criteria. Unsupervised clustering used body mass index (BMI), fasting glucose, fasting insulin, total testosterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and sex hormone-binding globulin (SHBG) across multiply imputed datasets. Phenotypes were characterized using additional reproductive, androgenic, and metabolic traits. Metabolic analyses were adjusted for age and BMI, with sensitivity analyses for missing postload outcomes. Two phenotypes were identified, Metabolic-PCOS in 657 women (37.9%) and Reproductive-PCOS in 1078 (62.1%). Reproductive-PCOS showed a gonadotropin-predominant profile, whereas Metabolic-PCOS showed a less favorable metabolic profile. Separation between these profiles was modest, supporting their interpretation as predominant clinical patterns rather than sharply distinct categories. Metabolic-PCOS also had higher 2-h glucose, 120-min insulin, triglycerides, low-density lipoprotein cholesterol (LDL-C), and uric acid, which were not used for phenotype derivation. After adjustment, 2-h glucose was 16.4% higher, 120-min insulin was 111.6% higher, and the odds of elevated 2-h glucose (≥7.8 mmol/L) were greater (odds ratio [OR] 3.98, 95% confidence interval [CI] 2.62 to 6.04). Findings were consistent across sensitivity analyses. This parsimonious biomedical data mining approach identified clinically interpretable PCOS phenotypes that warrant external and prospective validation for metabolic risk stratification.

BioengineeringVol. 13(11)
Shanghai Jiao Tong University (CN), Renji Hospital (CN), Shanghai Key Laboratory of Gynecologic Oncology (CN)
Science and Technology Commission of Shanghai Municipality, National Key Research and Development Program of China
Good health and well-being
Ovarian function and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon